Hepatic acute phase proteins - Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling

European Journal of Cell Biology

Volumn 91, Issue 6-7, 2012, Pages 496-505

  Bode, Johannes G ^a   Albrecht, Ute ^a   Häussinger, Dieter ^a   Heinrich, Peter C ^b,c   Schaper, Fred ^c,d  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Acute phase proteins; Acute phase response; Inflammatory cytokines; Liver; NF B; STAT3

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; FIBRINOGEN; HEPCIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEINASE INHIBITOR; SERUM AMYLOID A; STAT3 PROTEIN;

GENE EXPRESSION; INJURY; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR; UPREGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIVER; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84860250390     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.09.008     Document Type: Short Survey

References (86)

1. Agrawal A., Cha-Molstad H., Samols D., Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBPbeta) and Rel p50. J. Immunol. 2001, 166:2378-2384.
2. Agrawal A., Cha-Molstad H., Samols D., Kushner I. Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. Immunology 2003, 108:539-547.
3. Agrawal A., Samols D., Kushner I. Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter. Mol. Immunol. 2003, 40:373-380.
4. Akira S., Nishio Y., Inoue M., Wang X.J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994, 77:63-71.
5. Albrecht U., Yang X., Asselta R., Keitel V., Tenchini M.L., Ludwig S., Heinrich P.C., Häussinger D., Schaper F., Bode J.G. Activation of NF-kappaB by IL-1beta blocks IL-6-induced sustained STAT3 activation and STAT3-dependent gene expression of the human gamma-fibrinogen gene. Cell. Signal. 2007, 19:1866-1878.
6. Alonzi T., Maritano D., Gorgoni B., Rizzuto G., Libert C., Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell. Biol. 2001, 21:1621-1632.
7. Andus T., Geiger T., Hirano T., Kishimoto T., Tran-Thi T.A., Decker K., Heinrich P.C. Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures. Eur. J. Biochem. 1988, 173:287-293.
8. Baumann H., Gauldie J. The acute phase response. Immunol. Today 1994, 15:74-80.
9. Betts J.C., Cheshire J.K., Akira S., Kishimoto T., Woo P. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 1993, 268:25624-25631.
10. Bisoendial R.J., Boekholdt S.M., Vergeer M., Stroes E.S., Kastelein J.J. C-reactive protein is a mediator of cardiovascular disease. Eur. Heart J. 2010, 31:2087-2091.
11. Bode J.G., Fischer R., Haussinger D., Graeve L., Heinrich P.C., Schaper F. The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J. Immunol. 2001, 167:1469-1481.
12. Bode J.G., Heinrich P.C. Interleukin-6 signaling during the acute-phase response of the liver. The Liver: Biology and Pathobiology 2001, 565-580. Lippincott Williams & Wilkins, Philadelphia. 4th ed. I.M. Arias, J.L. Boyer, F.V. Chisari, N. Fausto, D. Schachter, D.A. Shafritz (Eds.).
13. Bouwens L., De Bleser P., Vanderkerken K., Geerts B., Wisse E. Liver cell heterogeneity: functions of non-parenchymal cells. Enzyme 1992, 46:155-168.
14. Bouwman L.H., Roos A., Terpstra O.T., de Knijff P., van Hoek B., Verspaget H.W., Berger S.P., Daha M.R., Frolich M., van der Slik A.R., Doxiadis I.I., Roep B.O., Schaapherder A.F. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005, 129:408-414.
15. Cantor H.M., Dumont A.E. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967, 215:744-745.
16. Cha-Molstad H., Agrawal A., Zhang D., Samols D., Kushner I. The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J. Immunol. 2000, 165:4592-4597.
17. Crispe I.N. The liver as a lymphoid organ. Annu. Rev. Immunol. 2009, 27:147-163.
18. Decker K. The response of liver macrophages to inflammatory stimulation. Keio J. Med. 1998, 47:1-9.
19. Edbrooke M.R., Foldi J., Cheshire J.K., Li F., Faulkes D.J., Woo P. Constitutive and NF-kappa B-like proteins in the regulation of the serum amyloid A gene by interleukin 1. Cytokine 1991, 3:380-388.
20. Farrell D.H. Pathophysiologic roles of the fibrinogen gamma chain. Curr. Opin. Hematol. 2004, 11:151-155.
21. Fleming M.D. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematol. Am. Soc. Hematol. Educ. Program 2008, 151-158.
22. Fort A., Borel C., Migliavacca E., Antonarakis S.E., Fish R.J., Neerman-Arbez M. Regulation of fibrinogen production by microRNAs. Blood 2010, 116:2608-2615.
23. Fuller G.M., Zhang Z. Transcriptional control mechanism of fibrinogen gene expression. Ann. N. Y. Acad. Sci. 2001, 936:469-479.
24. Gabay C., Kushner I. Acute-phase proteins, other systemic responses to inflammation. N. Engl. J. Med. 1999, 340:448-454.
25. Ganz T., Nemeth E. Hepcidin and disorders of iron metabolism. Annu. Rev. Med. 2011, 62:347-360.
26. Gorczynski R.M. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol. Lett. 1992, 33:67-77.
27. Hagihara K., Nishikawa T., Isobe T., Song J., Sugamata Y., Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem. Biophys. Res. Commun. 2004, 314:363-369.
28. Hagihara K., Nishikawa T., Sugamata Y., Song J., Isobe T., Taga T., Yoshizaki K. Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression. Genes Cells 2005, 10:1051-1063.
29. Häussinger D., Kubitz R., Reinehr R., Bode J.G., Schliess F. Molecular aspects of medicine: from experimental to clinical hepatology. Mol. Aspects Med. 2004, 25:221-360.
30. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
31. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 1998, 334(Pt 2):297-314.
32. Hentze M.W., Muckenthaler M.U., Galy B., Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 2010, 142:24-38.
33. Huang H., Constante M., Layoun A., Santos M.M. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009, 113:3593-3599.
34. Jensen L.E., Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 1998, 334:489-503.
35. Jiang S.L., Samols D., Rzewnicki D., Macintyre S.S., Greber I., Sipe J., Kushner I. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J. Clin. Invest. 1995, 95:1253-1261.
36. Kaptein A., Paillard V., Saunders M. Dominant negative Stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 1996, 271:5961-5964.
37. Kern M., Popov A., Kurts C., Schultze J.L., Knolle P.A. Taking off the brakes: T cell immunity in the liver. Trends Immunol. 2010, 31:311-317.
38. Kim H.K., Baumann H. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J. Biol. Chem. 1997, 272:14571-14579.
39. Knapp S., Florquin S., Golenbock D.T., van der Poll T. Pulmonary lipopolysaccharide (LPS)-binding protein inhibits the LPS-induced lung inflammation in vivo. J. Immunol. 2006, 176:3189-3195.
40. Koj A., Rokita H., Kordula T., Kurdowska A., Travis J. Role of cytokines and growth factors in the induced synthesis of proteinase inhibitors belonging to acute phase proteins. Biomed. Biochim. Acta 1991, 50:421-425.
41. Kordula T., Rokita H., Koj A., Fiers W., Gauldie J., Baumann H. Effects of interleukin-6 and leukemia inhibitory factor on the acute phase response and DNA synthesis in cultured rat hepatocytes. Lymphokine Cytokine Res. 1991, 10:23-26.
42. Lee Y.M., Miau L.H., Chang C.J., Lee S.C. Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140. Mol. Cell. Biol. 1996, 16:4257-4263.
43. Lerner L., Henriksen M.A., Zhang X., Darnell J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 2003, 17:2564-2577.
44. Leu J.I., Crissey M.A., Leu J.P., Ciliberto G., Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Mol. Cell. Biol. 2001, 21:414-424.
45. Limmer A., Knolle P.A. Liver sinusoidal endothelial cells: a new type of organ-resident antigen-presenting cell. Arch. Immunol. Ther. Exp. (Warsz) 2001, 49(Suppl. 1):S7-S11.
46. Longley D.B., Steel D.M., Whitehead A.S. Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5'- and 3'-untranslated regions of its mRNA. J. Immunol. 1999, 163:4537-4545.
47. Lütticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T., Kishimoto T., Barbirri G., Pelligrini S., Sendtner M., Heinrich P.C., Horn F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 1994, 263:89-92.
48. Moshage H. Cytokines and the hepatic acute phase response. J. Pathol. 1997, 181:257-266.
49. Nishikawa T., Hagihara K., Serada S., Isobe T., Matsumura A., Song J., Tanaka T., Kawase I., Naka T., Yoshizaki K. Transcriptional complex formation of c-Fos STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J. Immunol. 2008, 180:3492-3501.
50. Ochrietor J.D., Harrison K.A., Zahedi K., Mortensen R.F. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes. Cytokine 2000, 12:888-899.
51. Oh J., Teoh H., Leiter L.A. Should C-reactive protein be a target of therapy?. Diabetes Care 2011, 34(Suppl. 2):S155-S160.
52. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276:7806-7810.
53. Peters M., Roeb E., Pennica D., Meyer zum Buschenfelde K.H., Rose-John S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS Lett. 1995, 372:177-180.
54. Pietrangelo A., Dierssen U., Valli L., Garuti C., Rump A., Corradini E., Ernst M., Klein C., Trautwein C. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007, 132:294-300.
55. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 1998, 273:29279-29282.
56. Quinton L.J., Jones M.R., Robson B.E., Mizgerd J.P. Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect. Immun. 2009, 77:2417-2426.
57. Radtke S., Wuller S., Yang X.P., Lippok B.E., Mutze B., Mais C., de Leur H.S., Bode J.G., Gaestel M., Heinrich P.C., Behrmann I., Schaper F., Hermanns H.M. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J. Cell Sci. 2010, 123:947-959.
58. Ray S., Lee C., Hou T., Bhakat K.K., Brasier A.R. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol. Endocrinol. 2010, 24:391-401.
59. Rogers J.T., Bridges K.R., Durmowicz G.P., Glass J., Auron P.E., Munro H.N. Translational control during the acute phase response: Ferritin synthesis in response to interleukin-1. J. Biol. Chem. 1990, 265:14572-14578.
60. Sakamori R., Takehara T., Ohnishi C., Tatsumi T., Ohkawa K., Takeda K., Akira S., Hayashi N. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 2007, 46:1564-1573.
61. Sander L.E., Sackett S.D., Dierssen U., Beraza N., Linke R.P., Muller M., Blander J.M., Tacke F., Trautwein C. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 2010, 207:1453-1464.
62. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
63. Schooltink H., Stoyan T., Roeb E., Heinrich P.C., Rose-John S. Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Lett. 1992, 314:280-284.
64. Stassen J.M., Arnout J., Deckmyn H. The hemostatic system. Curr. Med. Chem. 2004, 11:2245-2260.
65. Steel D.M., Rogers J.T., DeBeer M.C., DeBeer F.C., Whitehead A.S. Biosynthesis of human acute-phase serum amyloid A protein (A-SAA) in vitro: the roles of mRNA accumulation, poly(A) tail shortening and translational efficiency. Biochem. J. 1993, 291(Pt 3):701-707.
66. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol. 2010, 10:753-766.
67. Tiegs G., Lohse A.W. Immune tolerance: what is unique about the liver. J. Autoimmun. 2010, 34:1-6.
68. Tillett W.S., Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J. Exp. Med. 1930, 52:561-571.
69. Ugarova T.P., Yakubenko V.P. Recognition of fibrinogen by leukocyte integrins. Ann. N. Y. Acad. Sci. 2001, 936:368-385.
70. Verga Falzacappa M.V., Vujic Spasic M., Kessler R., Stolte J., Hentze M.W., Muckenthaler M.U. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007, 109:353-358.
71. Voleti B., Agrawal A. Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter. J. Immunol. 2005, 175:3386-3390.
72. Wang Y., Ripperger J., Fey G.H., Samols D., Kordula T., Wetzler M., Van Etten R.A., Baumann H. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Hepatology 1999, 30:682-697.
73. Wegenka U.M., Buschmann J., Lütticken C., Heinrich P.C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 1993, 13:276-288.
74. Wegenka U.M., Lutticken C., Buschmann J., Yuan J., Lottspeich F., Muller-Esterl W., Schindler C., Roeb E., Heinrich P.C., Horn F. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol. Cell. Biol. 1994, 14:3186-3196.
75. Wisse E., Braet F., Luo D., De Zanger R., Jans D., Crabbe E., Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 1996, 24:100-111.
76. Wuestefeld T., Klein C., Streetz K.L., Betz U., Lauber J., Buer J., Manns M.P., Muller W., Trautwein C. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J. Biol. Chem. 2003, 278:11281-11288.
77. Yang X.P., Albrecht U., Zakowski V., Sobota R.M., Haussinger D., Heinrich P.C., Ludwig S., Bode J.G., Schaper F. Dual function of interleukin-1beta for the regulation of interleukin-6-induced suppressor of cytokine signaling 3 expression. J. Biol. Chem. 2004, 279:45279-45289.
78. Yoshida Y., Kumar A., Koyama Y., Peng H., Arman A., Boch J.A., Auron P.E. Interleukin 1 activates STAT3/nuclear factor-kappaB cross-talk via a unique TRAF6- and p65-dependent mechanism. J. Biol. Chem. 2004, 279:1768-1776.
79. Yu Z., Zhang W., Kone B.C. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem. J. 2002, 367:97-105.
80. Yuan Z.L., Guan Y.J., Chatterjee D., Chin Y.E. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 2005, 307:269-273.
81. Zauberman A., Lapter S., Zipori D. Smad proteins suppress CCAAT/enhancer-binding protein (C/EBP) beta- and STAT3-mediated transcriptional activation of the haptoglobin promoter. J. Biol. Chem. 2001, 276:24719-24725.
82. Zhang D., Sun M., Samols D., Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 1996, 271:9503-9509.
83. Zhang X., Wrzeszczynska M.H., Horvath C.M., Darnell J.E. Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol. Cell. Biol. 1999, 19:7138-7146.
84. Zhang Z., Fuentes N.L., Fuller G.M. Characterization of the IL-6 responsive elements in the gamma fibrinogen gene promoter. J. Biol. Chem. 1995, 270:24287-24291.
85. Zhang Z., Fuller G.M. The competitive binding of STAT3 and NF-kappaB on an overlapping DNA binding site. Biochem. Biophys. Res. Commun. 1997, 237:90-94.
86. Zhang Z., Fuller G.M. Interleukin 1beta inhibits interleukin 6-mediated rat gamma fibrinogen gene expression. Blood 2000, 96:3466-3472.